Patrys Limited (ASX:PAB)

Share Price Chart

About Patrys Limited

Key Information

PAB In the News

Patrys (PAB) has flagged delays to the phase one clinical trial of…
Patrys (PAB) has claimed a recent pre-clinical study of its PAT-DX3 drug…
Patrys (PAB) subsidiary Nucleus Therapeutics has received a $3.35 million research and…
Patrys (PAB) confirms its PAT-DX3 antibody can cross the blood-brain barrier in…

ASX Announcements

Share Price History

Officers & Directors

Insider Transactions

Shareholder Information

Health Care Sector News